Skip to content

Prevention of oral cancer by tea

Prevention of oral cancer by tea: a mechanism study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN70410203
Enrollment
64
Registered
2012-01-06
Start date
2006-02-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral cancer Cancer Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention agents (each 5 cups per day): 1. Green tea 2. Black tea 3. Caffeinated water 4. Placebo water The tea (400 mg of tea powder per cup), caffeinated water (same concentration as

Sponsors

Georgetown University (USA)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Must be aged 18 to 60 years 2. Potential subjects should have been smoking for at least two years and be currently smoking at least 1/2 pack (10 cigarettes) per day 3. Subjects should be, in general, on a low flavonoid diet (low plant-based diet)

Exclusion criteria

Exclusion criteria: 1. Allergic to tea or caffeine 2. Have oral leukoplakia or evidence of oral lesions 3. Regularly take medications containing caffeine, principally analgesics and 'cold' medicines (American Drug Index 1999) 4. Habitually drink more than two cups of coffee, tea, or caffeinated sodas per day 5. Habitually drink energy drinks (such as Red Bull, Jolt, Monster, etc.) each day 6. Drink more than two servings in one day of: 40% proof alcoholic beverages (3 oz), beer (12 oz), wine (6 oz), or any cocktail 7. Suffering from cancer 8. Have been treated with chemotherapy or radiotherapy within the past five years 9. Have cardiac arrhythmias or other heart disease or have been advised not to take excessive caffeine 10. Strict vegetarians 11. Taking alternative medications that have primarily an antioxidant effect (American Drug Index 1999) 12. Taking Vitamin A, C and E in doses > 1-1/2 x the RDA 13. Have serum levels of Vitamin A, serum carotenoids or alpha-tocopherol above the upper limits of normal 14. Have high blood pressure

Design outcomes

Primary

MeasureTime frame
1. Markers of DNA damage (8-OH guanine) 2. Tobacco carcinogen metabolites (cyclic adducts) 3. Apoptosis

Secondary

MeasureTime frame
No secondary outcome measures

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026